← Back to Search

Dignity Therapy - Chaplain Led for Cancer

N/A
Waitlist Available
Led By George Fitchett, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights

Study Summary

This trial will help elderly cancer patients maintain their pride, find spiritual comfort, and make meaning of their illness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dignity Impact Scale
Secondary outcome measures
Completion
Peaceful Awareness
Preparation
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Dignity Therapy - Nurse LedExperimental Treatment1 Intervention
During the experimental steps as part of routine palliative care service delivery, patients receive nurse-led DT.
Group II: Dignity Therapy - Chaplain LedExperimental Treatment1 Intervention
During the experimental steps as part of routine palliative care service delivery, patients will receive chaplain-led DT.
Group III: usual outpatient palliative careActive Control1 Intervention
During the usual care steps, patients will receive usual outpatient palliative care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dignity Therapy - Nurse Led
2017
N/A
~580
Dignity Therapy - Chaplain Led
2017
N/A
~580

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,117 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,574 Total Patients Enrolled
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
916,652 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Journal of Palliative MedicineJournal
Is the Palliative Performance Scale a Useful Predictor of Mortality in a Heterogeneous Hospice Population?
Harrold, Joan, Elizabeth Rickerson, Janet T. Carroll, Jennifer McGrath, Knashawn Morales, Jennifer Kapo, and David Casarett. 2005. “Is the Palliative Performance Scale a Useful Predictor of Mortality in a Heterogeneous Hospice Population?”. Journal of Palliative Medicine. Mary Ann Liebert Inc. doi:10.1089/jpm.2005.8.503.
BMC Medical Research MethodologyJournal
The Stepped Wedge Trial Design: A Systematic Review
Brown, Celia A, and Richard J Lilford. 2006. “The Stepped Wedge Trial Design: A Systematic Review”. BMC Medical Research Methodology. Springer Science and Business Media LLC. doi:10.1186/1471-2288-6-54.
clinicaltrials.govStudy
Palliative Care for Elderly Outpatients
2017. "Palliative Care for Elderly Outpatients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03209440.
~76 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top